Syk-IN-4
Syk-IN-4 is a potent, selective and orally bioavailable SYK inhibitor with an IC50 of 0.31 nM. SYK has emerged as a potential target for autoimmunity and hematological cancers[1].
Product Specifications
CAS Number
[2932264-95-2]
UNSPSC
12352005
Target
Syk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/syk-in-4.html
Concentration
10mM
Purity
98.0
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
CC1=NN(C=C1CN(C)C)C2=NC(NC3=CC=C(N(C)N=C4C(NC)=O)C4=C3)=NC=C2
Molecular Formula
C21H25N9O
Molecular Weight
419.48
References & Citations
[1]Neil P Grimster, et al. Optimization of a Series of Potent, Selective and Orally Bioavailable SYK Inhibitors. Bioorg Med Chem Lett. 2020 Jul 24;127433.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15333299 1 Vial
Lentiviral human RAP1GAP2 shRNA (UAS) - Lentiviral human RAP1GAP2 shRNA (UAS, GFP) (25)
Ask
View Details 
HY-W099125R 1 Each
Diethyl 5,5'- ((2-hydroxypropane-1,3-diyl) bis (oxy) ) bis (4-oxo-4H-chromene-2-carboxylate) (Standard)
Ask
View Details